Navigation Links
Agendia Appoints New Chief Financial Officer
Date:1/8/2009

HUNTINGTON BEACH, California, and AMSTERDAM, January 8 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Kurt Schmidt, CPA, MBA, as the company's new Chief Financial Officer.

"Kurt is an exceptional addition to our team and an invaluable asset," said Bernhard Sixt, Ph.D., President and Chief Executive Officer. "With his extensive financial management experience in the high tech and healthcare industries, he will be instrumental in driving Agendia's next phase of growth."

Mr. Schmidt succeeds former Chief Financial Officer, John de Die, who has been an exemplary guide for Agendia during his tenure. Mr. Schmidt brings more than 25 years of financial, operational and entrepreneurial management experience, primarily in the high tech and healthcare industries in the U.S. and Europe. Most recently, he was a principal at a consulting firm he founded in 2002, providing high-level interim financial management and M&A services. Prior to that, Mr. Schmidt served as Operations Director at B2eMarkets, a supply chain technology company, and Director of Finance & Operations at LA Gear Europe. Mr. Schmidt started his career at Cardinal Health, Inc. in corporate finance.

"I am delighted to join Agendia during this exciting time and help prepare the company for our next financing round. I look forward to our first investor meetings next week during the JP Morgan Healthcare Conference in San Francisco," commented Kurt Schmidt, Chief Financial Officer.

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer treatments. The company markets four products, with several new genomic tests under development. In addition, Agendia collaborates with pharmaceutical companies to develop highly effective personalized drugs in the area of oncology. Agendia was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands. For more information please visit http://www.agendia.com.


'/>"/>
SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
2. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
3. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
4. Agendia BV Appoints Clinical and Scientific Advisory Board
5. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
6. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
7. Agendia Joins the Personalized Medicine Coalition (PMC)
8. Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board
9. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
10. Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
11. Algeta Appoints Andrew Kay as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... , Jan. 16, 2017   Valentin A. ... Tracey, MD , president and CEO of The ... completed an analysis of how the nervous system regulates ... and develop bioelectronic medicine devices to treat ... Nature Neuroscience . The paper examines ...
(Date:1/13/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The biosimilars market is expected to reach USD ... a CAGR of 26.3%. The global biosimilars market ... Factors such as rising incidence of various diseases, increasing demand for ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... Vertebral Technologies, Inc., announces the successful outcome of the first lumbar fusion ... VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based medical product company BioMedical ...
(Date:1/12/2017)... 12, 2017 The Energy and ... facility for producing mycorrhizae. The Centre for Mycorrhizal Research ... of mycorrhizae and developed a technology that eventually produces ... ... The TERI facility has a production capacity ...
Breaking Biology Technology:
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
(Date:12/20/2016)... , Dec. 20, 2016 The rising ... rental and leasing is stoking significant interest in ... frequency technology, Bluetooth low energy (BLE), biometrics and ... the next wave of wireless technologies in the ... system to advanced access systems opens the market ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
Breaking Biology News(10 mins):